Spinal Cord Injuries — Long-term Outcomes and Life Satisfaction of Adults With Pediatric-Onset Spinal Cord Injuries
Citation(s)
Anderson CJ, Krajci KA, Vogel LC Life satisfaction in adults with pediatric-onset spinal cord injuries. J Spinal Cord Med. 2002 Fall;25(3):184-90.
Anderson CJ, Vogel LC, Betz RR, Willis KM Overview of adult outcomes in pediatric-onset spinal cord injuries: implications for transition to adulthood. J Spinal Cord Med. 2004;27 Suppl 1:S98-106.
Anderson CJ, Vogel LC, Chlan KM, Betz RR Coping with spinal cord injury: strategies used by adults who sustained their injuries as children or adolescents. J Spinal Cord Med. 2008;31(3):290-6.
Anderson CJ, Vogel LC, Willis KM, Betz RR Stability of transition to adulthood among individuals with pediatric-onset spinal cord injuries. J Spinal Cord Med. 2006;29(1):46-56.
Anderson CJ, Vogel LC Employment outcomes of adults who sustained spinal cord injuries as children or adolescents. Arch Phys Med Rehabil. 2002 Jun;83(6):791-801.
Chlan KM, Zebracki K, Vogel LC Spirituality and life satisfaction in adults with pediatric-onset spinal cord injury. Spinal Cord. 2011 Mar;49(3):371-5. doi: 10.1038/sc.2010.80. Epub 2010 Jul 6.
Deane KC, Chlan KM, Vogel LC, Zebracki K Use of Appraisals of DisAbility Primary and Secondary Scale-Short Form (ADAPSS-sf) in individuals with pediatric-onset spinal cord injury. Spinal Cord. 2020 Mar;58(3):290-297. doi: 10.1038/s41393-019-0375-0. Epub 2019 Nov 7.
Hwang M, Chlan KM, Vogel LC, Zebracki K Substance use in young adults with pediatric-onset spinal cord injury. Spinal Cord. 2012 Jul;50(7):497-501. doi: 10.1038/sc.2012.8. Epub 2012 Feb 28.
Hwang M, Zebracki K, Chlan KM, Vogel LC Longitudinal changes in medical complications in adults with pediatric-onset spinal cord injury. J Spinal Cord Med. 2014 Mar;37(2):171-8. doi: 10.1179/2045772313Y.0000000150. Epub 2013 Nov 26.
Hwang M, Zebracki K, Chlan KM, Vogel LC Longitudinal employment outcomes in adults with pediatric-onset spinal cord injury. Spinal Cord. 2014 Jun;52(6):477-82. doi: 10.1038/sc.2014.32. Epub 2014 Mar 25.
Hwang M, Zebracki K, Vogel LC Long-Term Outcomes and Longitudinal Changes of Neurogenic Bowel Management in Adults With Pediatric-Onset Spinal Cord Injury. Arch Phys Med Rehabil. 2017 Feb;98(2):241-248. doi: 10.1016/j.apmr.2016.07.004. Epub 2016 Jul 26.
Hwang M, Zebracki K, Vogel LC Medication profile and polypharmacy in adults with pediatric-onset spinal cord injury. Spinal Cord. 2015 Sep;53(9):673-8. doi: 10.1038/sc.2015.62. Epub 2015 Apr 21.
Hwang M, Zebracki K, Vogel LC Occupational characteristics of adults with pediatric-onset spinal cord injury. Top Spinal Cord Inj Rehabil. 2015 Winter;21(1):10-9. doi: 10.1310/sci2101-10.
January AM, Kirk S, Zebracki K, Chlan KM, Vogel LC Psychosocial and Health Outcomes of Adults With Violently Acquired Pediatric Spinal Cord Injury. Top Spinal Cord Inj Rehabil. 2018 Fall;24(4):363-370. doi: 10.1310/sci17-00012. Epub 2018 Feb 12.
January AM, Zebracki K, Chlan KM, Vogel LC Mental health and risk of secondary medical complications in adults with pediatric-onset spinal cord injury. Top Spinal Cord Inj Rehabil. 2014 Winter;20(1):1-12. doi: 10.1310/sci2001-1.
January AM, Zebracki K, Chlan KM, Vogel LC Poor sleep in adults with pediatric-onset spinal cord injury: associations with pain, health, and activity. J Spinal Cord Med. 2017 Sep;40(5):560-566. doi: 10.1080/10790268.2017.1308109. Epub 2017 Apr 10.
January AM, Zebracki K, Chlan KM, Vogel LC Sleep, well-being, and psychological symptoms in adults with pediatric-onset spinal cord injury. Rehabil Psychol. 2015 Nov;60(4):328-34. doi: 10.1037/rep0000061.
January AM, Zebracki K, Chlan KM, Vogel LC Symptoms of depression over time in adults with pediatric-onset spinal cord injury. Arch Phys Med Rehabil. 2014 Mar;95(3):447-54. doi: 10.1016/j.apmr.2013.11.011. Epub 2013 Dec 4.
January AM, Zebracki K, Chlan KM, Vogel LC Understanding post-traumatic growth following pediatric-onset spinal cord injury: the critical role of coping strategies for facilitating positive psychological outcomes. Dev Med Child Neurol. 2015 Dec;57(12):11
January AM, Zebracki K, Czworniak A, Chlan KM, Vogel LC Predictive factors of hospitalization in adults with pediatric-onset SCI: a longitudinal analysis. Spinal Cord. 2015 Apr;53(4):314-9. doi: 10.1038/sc.2015.13. Epub 2015 Feb 10.
Murray CB, Zebracki K, Chlan KM, Moss AC, Vogel LC Medical and psychological factors related to pain in adults with pediatric-onset spinal cord injury: a biopsychosocial model. Spinal Cord. 2017 Apr;55(4):405-410. doi: 10.1038/sc.2016.137. Epub 2016 Sep
Vogel LC, Chlan KM, Zebracki K, Anderson CJ Long-term outcomes of adults with pediatric-onset spinal cord injuries as a function of neurological impairment. J Spinal Cord Med. 2011;34(1):60-6.
Vogel LC, Krajci KA, Anderson CJ Adults with pediatric-onset spinal cord injuries: part 3: impact of medical complications. J Spinal Cord Med. 2002 Winter;25(4):297-305.
Vogel LC, Krajci KA, Anderson CJ Adults with pediatric-onset spinal cord injury: part 1: prevalence of medical complications. J Spinal Cord Med. 2002 Summer;25(2):106-16.
Vogel LC, Krajci KA, Anderson CJ Adults with pediatric-onset spinal cord injury: part 2: musculoskeletal and neurological complications. J Spinal Cord Med. 2002 Summer;25(2):117-23.
Zebracki, K , Anderson, C., Chlan, K., & Vogel, L. (2010). Outcomes of adults with pediatric-onset spinal cord injury: Longitudinal findings and implications on transition to adulthood. Topics in Spinal Cord Injury Rehabilitation, 16(1), 17-25. Doi: 10.13
Long-term Outcomes and Life Satisfaction of Adults With Pediatric-Onset Spinal Cord Injuries
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
